What is Pamidronate Intravenous
Pamidronate intravenous (brand name Aredia) is a medication used to treat cancer. It belongs to a class of drugs called bisphosphonates, which work by slowing down the breakdown of bone. Pamidronate can be given intravenously (by injection into a vein) or orally (by mouth).
Benefits of Pamidronate Intravenous
and Its Uses.
Pamidronate is a medication that is used to treat a variety of conditions, including cancer, Paget’s disease, and bone damage from multiple myeloma. It is a type of bisphosphonate, a class of drugs that helps to protect bone health. When used intravenously, pamidronate can help to improve bone density and reduce the risk of fractures. It can also help to improve symptoms in people with cancer who have bone metastases.
Side Effects and Dosage of Pamidronate Intravenous
Pamidronate (Aredia) is a bisphosphonate drug prescribed to treat Paget’s disease, bone metastases, and osteoporosis. It is also used off-label to prevent post-menopausal bone loss. Pamidronate is available as an intravenous (IV) infusion. The most common side effects of pamidronate include:
bone, joint, or muscle pain
These side effects usually improve after a few doses of the medication.
Pamidronate is usually given as a single dose or over a few days. The dose and schedule will depend on the condition being treated.